公司概覽
業務類別 Biotechnology
業務概覽 Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
公司地址 3027 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361
電話號碼 +1 805 418-5006
傳真號碼 --
公司網頁 https://www.arcutis.com
員工數量 354
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Patrick E. Burnett, M.D.,PhD Executive Vice President and Chief Medical Officer 美元 535.00K 21/04/2026
Mr. Robert Lisicki Interim Executive Vice President and Interim Chief Commercial Officer -- 05/08/2026
Mr. Masaru Matsuda, J.D. Executive Vice President, Chief Legal Officer and Corporate Secretary 美元 495.17K 21/04/2026
Mr. Todd Franklin Watanabe Director, President and Chief Executive Officer 美元 713.33K 21/04/2026
Ms. Latha Vairavan Principal Accounting Officer, Senior Vice President and Chief Financial Officer 美元 419.49K 21/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Keith R. Leonard, Jr Chairman of the Board 21/04/2026
Mr. Patrick J. Heron Independent Director 21/04/2026
Ms. Halley E. Gilbert Independent Director 21/04/2026
Mr. Amit D. Munshi Independent Director 21/04/2026
Mr. Christopher Peetz Independent Director 16/07/2026
Ms. Terrie Curran Independent Director 21/04/2026
Mr. Todd Franklin Watanabe Director, President and Chief Executive Officer 21/04/2026
Dr. Howard G. Welgus, M.D. Independent Director 21/04/2026
Ms. Neha Krishnamohan Independent Director 21/04/2026
Ms. Sue-Jean Lin Independent Director 21/04/2026
Mr. Robert Scott Independent Director 28/10/2026
 
所屬ETF (更新日期: 07/11/2026 02:45)
代號 名稱 佔比% ▼ 持有日期
FYXFirst Trust Small Cap Core AlphaDEX® ETF0.10%29/10/2026
VTWGVanguard Russell 2000 Growth ETF0.10%30/09/2026
FSCCFederated Hermes MDT Small Cap Core ETF0.09%30/10/2026
PSCHInvesco S&P SmallCap Health Care ETF0.08%30/10/2026
GSSCGoldman Sachs ActiveBeta® US SmCp Eq ETF0.07%30/10/2026
ESMLiShares ESG Aware MSCI USA Small-Cap ETF0.07%30/10/2026
RZGInvesco S&P SmallCap 600® Pure Gr ETF0.06%30/10/2026
BBPVirtus Biotech ETF0.06%30/10/2026
SCHBSchwab US Broad Market ETF™0.05%31/10/2026
DWASInvesco Dorsey Wright SmallCap Momt ETF0.05%30/10/2026
FHLCFidelity MSCI Health Care ETF0.05%30/10/2026
SEISSEI Select Small Cap ETF0.04%30/10/2026
PRFZInvesco RAFI US 1500 Small-Mid ETF0.04%30/10/2026
ISCGiShares Morningstar Small-Cap Growth ETF0.03%30/10/2026
ONEQFidelity Nasdaq Composite ETF0.03%30/10/2026
BBSCJPMorgan BetaBuilders US Sml Cp Eq ETF0.03%30/10/2026
IWViShares Russell 3000 ETF0.03%30/10/2026
GURUGlobal X Guru™ ETF0.03%30/10/2026
RWJInvesco S&P SmallCap 600 Revenue ETF0.02%30/10/2026
SMLFiShares U.S. Small-Cap Eq Fac ETF0.02%30/10/2026
  1   2    3    4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.